Table 2.
Characteristic | GEE coefficient (95% CI) | P |
---|---|---|
Men | Reference | |
Women | −0.13 (−1.4, 1.1) | 0.84 |
Age, years | −0.02 (−0.05, 0.03) | 0.47 |
University hospital, HAQ score | ||
First quartile | Reference | |
Second quartile | 2.8 (1.7, 3.9) | <0.0001 |
Third quartile | 4.7 (3.4, 6.0) | <0.0001 |
Fourth quartile | 9.1 (6.8, 11.3) | <0.0001 |
Public hospital, HAQ score | ||
First quartile | 0.99 (−0.08, 2.1) | 0.07 |
Second quartile | 3.3 (2.1, 4.6) | <0.0001 |
Third quartile | 7.0 (5.8, 8.3) | <0.0001 |
Fourth quartile | 11.7 (9.8, 13.7) | <0.0001 |
Disease duration, years | −0.02 (−0.07, 0.03) | 0.37 |
DMARD† | ||
No | Reference | |
Yes | −0.47 (−1.6, 0.66) | 0.42 |
Prednisone | −0.39 (−1.3, 0.55) | 0.41 |
GEE = generalized estimating equation; 95% CI = 95% confidence interval; HAQ = Health Assessment Questionnaire; DMARD = disease-modifying antirheumatic drug.
Includes any DMARD other than prednisone.